Krka, d. d.
KRK
주식 순위
#2157
Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved... Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved in the research, production, promotion, and sale of various pharmaceutical goods. Its market presence spans Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and numerous other international territories. The company's offerings are categorized into prescription medications, over-the-counter products, and veterinary health solutions. Its prescription drug pipeline targets a broad spectrum of medical conditions, including cardiovascular disorders, gastrointestinal issues, central nervous system ailments, pain management, anti-infective treatments, conditions affecting blood and blood-forming organs, urological problems, diabetes, and oncology. The array of non-prescription items includes products for oral and throat care, cough and cold remedies, analgesics, nasal preparations, vitamin and mineral supplements, products designed to enhance cerebral and peripheral circulation, digestive aids, and various general healthcare products. Furthermore, Krka supplies animal health products such as anti-infectives, antiparasitics, and other specialized formulations for both livestock and companion animals. Beyond its pharmaceutical operations, the company also provides health resort and tourist services. Krka, d. d. was established in 1954 and has its corporate headquarters in Novo Mesto, Slovenia.
주가
$313.05
시가총액
$9.48B
변동 (1일)
-1.77%
변동 (1년)
35.37%
국가
SI
거래 Krka, d. d. (KRK)
카테고리
Healthcare
Krka, d. d. (KRK)의 EPS
June 2026 기준 EPS TTM: $16.04
Krka, d. d.의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $16.04입니다. 2023년 말에는 회사의 EPS가 $11.21였으며, 이는 2022년의 EPS $12.54와 감소입니다.
Krka, d. d.의 EPS 기록 (2010 ~ 2026)
매년 말의 EPS
| 연도 | EPS | 변화 |
|---|---|---|
| 2026 (TTM) | $16.04 | 32.86% |
| 2024 | $12.07 | 7.68% |
| 2023 | $11.21 | -10.61% |
| 2022 | $12.54 | 11.16% |
| 2021 | $11.28 | -0.08% |
| 2020 | $11.29 | 30.17% |
| 2019 | $8.67 | 38.23% |
| 2018 | $6.27 | 10.32% |
| 2017 | $5.69 | 61.36% |
| 2016 | $3.52 | -33.21% |
| 2015 | $5.28 | -13.98% |
| 2014 | $6.13 | -14.87% |
| 2013 | $7.21 | 13.81% |
| 2012 | $6.33 | 0.85% |
| 2011 | $6.28 | -7.19% |
| 2010 | $6.77 | 0.00% |
유사 기업 또는 경쟁사의 EPS
| 회사 | EPS | EPS 차이 | 국가 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -96.53% |
IN
|
